USADA announced today that Logan Storie, of Fayetteville, N.C., an athlete in the sport of pentathlon, has accepted a six-year suspension for his second anti-doping rule violation. Storie’s first violation was announced on February 24, 2017, when he received a 15-month suspension from Union Internationale de Pentathlon Moderne (UIPM) after testing positive for androsterone and etiocholanolone.
Storie, 32, tested positive for ostarine (enobosarm) and GW1516 (GW501516), as well as LGD-4033 (ligandrol) and its metabolite di-hydroxy-LGD-4033, as the result of a sample collected out of competition on October 23, 2020. Ostarine and LGD‐4033 are Non-Specified Substances in the class of Anabolic Agents, while GW1516 is a Non-Specified Substance in the class of Hormone and Metabolic Modulators. Each of these substances is prohibited at all times under the USADA Protocol for Olympic and Paralympic Movement Testing, the United States Olympic and Paralympic Committee National Anti-Doping Policy, and the UPIM Anti-Doping Rules, all of which have adopted the World Anti-Doping Code (the Code) and the World Anti-Doping Agency (WADA) Prohibited List.
Under the rule governing second violations in the 2021 Code, the length of the period of ineligibility for a second violation may be up to double the otherwise applicable sanction, treated as if it were a first violation. Because Storie tested positive for Non-Specified Substances, the period of ineligibility for a first violation would be four years, making the maximum sanction for a second violation eight years. Storie received a reduction from the eight-year sanction for providing substantial assistance.
Storie accepted a six-year period of ineligibility that began on October 23, 2020, the date his positive sample was collected. Because Storie was tested out of competition and has not competed since October 23, 2020, there are no competitive results to disqualify.
The original article can be found here.